Wits roll out second COVID vaccine trials in South Africa
South Africa's second round of vaccine trials for the coronavirus has begun. The Bill and Melinda Gates Foundation also donated millions of dollars to American Company Novavax for vaccine trials in South Africa. Please don't forget to follow me and share this exciting news.
The first round of trials began on the 23rd of June for the Ox1Cov-19 Vaccine Vida-Trial with Oxford university and the Jenner institute and was said to have been processing well. The second trial will now be screening volunteers for the NVX-CoV2373 vaccine, which is produced by Novavax, a Biotech American company.
This second trial will have about 2900 volunteers between the ages of 18 and 64. The NVX-CoV2373 vaccine uses the genetics sequence of the virus that causes the coronavirus.
This trials will make South Africans to be one of the first to have access to the vaccines when they become available. "This current vaccine has already undergone phase 1 studies", said Madhi. The phase 2 study will assist in knowing the safety of the vaccine, how the body responds to it and whether it can protect against the virus.
The vaccine trials will also deal with how the vaccine would work for those positive with HIV, which shows inclusivity and further efficiency.
Do you think the vaccine trials will go well? Leave your opinion by commenting below.
Content created and supplied by: Sellalasekele (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More